<SEC-DOCUMENT>0001493152-20-000333.txt : 20200108
<SEC-HEADER>0001493152-20-000333.hdr.sgml : 20200108
<ACCEPTANCE-DATETIME>20200108073002
ACCESSION NUMBER:		0001493152-20-000333
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		4
CONFORMED PERIOD OF REPORT:	20200108
ITEM INFORMATION:		Regulation FD Disclosure
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20200108
DATE AS OF CHANGE:		20200108

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Microbot Medical Inc.
		CENTRAL INDEX KEY:			0000883975
		STANDARD INDUSTRIAL CLASSIFICATION:	BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
		IRS NUMBER:				943078125
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-19871
		FILM NUMBER:		20514519

	BUSINESS ADDRESS:	
		STREET 1:		175 DERBY ST. 27/1
		STREET 2:		.
		CITY:			HINGHAM
		STATE:			MA
		ZIP:			02043
		BUSINESS PHONE:		908-938-5561

	MAIL ADDRESS:	
		STREET 1:		175 DERBY ST. 27/1
		STREET 2:		.
		CITY:			HINGHAM
		STATE:			MA
		ZIP:			02043

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	STEMCELLS INC
		DATE OF NAME CHANGE:	20000524

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	CYTOTHERAPEUTICS INC/DE
		DATE OF NAME CHANGE:	19930328
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>form8-k.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0; padding: 0; font: 10pt Times New Roman, Times, Serif"></P>


<P STYLE="margin-top: 0; text-align: center; margin-bottom: 0; font: 10pt Times New Roman, Times, Serif; padding: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-top: 0; text-align: center; margin-bottom: 0; font: 10pt Times New Roman, Times, Serif; padding: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 0; margin-bottom: 0; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 4pt solid; border-bottom: Black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="margin-top: 0; text-align: center; margin-bottom: 0; font: 10pt Times New Roman, Times, Serif; padding: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<P STYLE="margin-top: 0; text-align: center; margin-bottom: 0; font: 10pt Times New Roman, Times, Serif; padding: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="margin-top: 0; text-align: center; margin-bottom: 0; font: 10pt Times New Roman, Times, Serif; padding: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 18pt"><B>UNITED
STATES</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 18pt"><B>SECURITIES
AND EXCHANGE COMMISSION</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 12pt"><B>Washington,
D.C. 20549</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 18pt"><B>FORM
8-K</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; padding: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; padding: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>CURRENT
REPORT</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; padding: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Pursuant
to Section 13 or 15(d)</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; padding: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>of
the Securities Exchange Act of 1934</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; padding: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; padding: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Date
of Report (Date of earliest event reported): January 8, 2020</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; padding: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; padding: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 18pt"><B>MICROBOT
MEDICAL INC.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; padding: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(Exact
name of registrant as specified in its charter)</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; padding: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 35%; font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Delaware</B></FONT></TD>
    <TD STYLE="width: 33%; font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>000-19871</B></FONT></TD>
    <TD STYLE="width: 32%; font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>94-3078125</B></FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; padding: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(State
        or other jurisdiction</B></FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; padding: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>of
        incorporation)</B></FONT></P></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><P STYLE="margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(Commission</B></FONT></P>
                                                                             <P STYLE="margin-top: 0; margin-bottom: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>File Number)</B></FONT></P></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; padding: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(IRS
        Employer</B></FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; padding: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Identification
        No.)</B></FONT></P></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; padding: 0; text-align: center; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>25 Recreation Park Drive, Unit 108</B></FONT> <FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Hingham, Massachusetts 02043</B></FONT></P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>(Address of Principal Executive Offices) (Zip Code)</B></FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Registrant&rsquo;s
telephone number, including area code: (781) 875-3605</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(Former
Name or Former Address, if Changed Since Last Report)</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; padding: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; padding: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Check
the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant
under any of the following provisions:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; padding: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 24px; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[&nbsp;&nbsp;]</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Written
    communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; padding: 0; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 24px; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[&nbsp;&nbsp;]</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Soliciting
    material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; padding: 0; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 24px; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[&nbsp;&nbsp;]</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pre-commencement
    communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; padding: 0; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 24px; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[&nbsp;&nbsp;]</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pre-commencement
    communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; padding: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; padding: 0; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Securities
registered pursuant to Section 12(b) of the Act:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; padding: 0; background-color: white"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 34%; font: 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Title
    of each class</B></FONT></TD>
    <TD STYLE="width: 2%; text-align: center; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="width: 22%; font: 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Trading
    Symbol(s)</B></FONT></TD>
    <TD STYLE="width: 2%; text-align: center; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="width: 40%; font: 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Name
    of each exchange on which registered</B></FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Common
    Stock, $0.01 par value</FONT></TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">MBOT</FONT></TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">NASDAQ
    Capital Market</FONT></TD></TR>
</TABLE>
<DIV STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-right: 0; margin-bottom: 0"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; padding: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; padding: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Indicate
by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR
&sect;230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR &sect;240.12b-2).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; padding: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; padding: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Emerging
Growth Company [&nbsp;&nbsp;]</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; padding: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; padding: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for
complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. [&nbsp;&nbsp;]</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; padding: 0; text-align: justify; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; padding: 0; text-align: justify; background-color: white"></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 0; margin-bottom: 0; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid; border-bottom: Black 4pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; padding: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

</DIV>


<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; padding: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 0.75in; font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Item
7.01</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Regulation
    FD Disclosure.</B></FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; padding: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; padding: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
January 8, 2020, Microbot Medical Inc. (the &ldquo;Company&rdquo;) issued a press release announcing that the Company has received
an official communication from the European Patent Office (EPO) regarding its intention to grant European Patent Application No.
11795301, covering the Company&rsquo;s Self-Cleaning Shunt (SCS&trade;). Globally, the Company now has 36 patents issued/allowed
and 16 patent applications pending worldwide.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; padding: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; padding: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
copy of the press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated herein by reference.
The information in this report (including Exhibit 99.1) is being furnished pursuant to Item 7.01 and shall not be deemed to be
&ldquo;filed&rdquo; for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to
the liabilities of that section. This report will not be deemed an admission as to the materiality of any information herein (including
Exhibit 99.1).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; padding: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 0.75in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Item
    9.01.</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Financial
    Statements and Exhibits.</B></FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; padding: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; padding: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>(d)
Exhibits</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; padding: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 0.65in; font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit</B></FONT></P>
                                                                     <P STYLE="margin-top: 0; margin-bottom: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Number</B></FONT></P></TD>
    <TD STYLE="width: 0.1in; font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Description</B></FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">99.1</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><A HREF="ex99-1.htm"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Press release, dated January 8, 2020</FONT></A></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; padding: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>


<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; padding: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; padding: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>SIGNATURES</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; padding: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; padding: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf
by the undersigned thereunto duly authorized.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; padding: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>MICROBOT
    MEDICAL INC.</B></FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 50%; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 5%; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="width: 45%; font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>/s/
    Harel Gadot</I></FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Harel
    Gadot</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief
    Executive Officer, President and Chairman</FONT></TD></TR>
</TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; padding: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date:
January 8, 2020</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; padding: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; padding: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; padding: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; padding: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>



<P STYLE="margin: 0; padding: 0; font: 10pt Times New Roman, Times, Serif"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>ex99-1.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit
99.1</B></FONT></P>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><IMG SRC="ex99-1_002.jpg" ALT="" STYLE="height: 78; width: 200"></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Microbot
Medical Receives Intention to Grant from European Patent Office for a Patent Application Covering its Self-Cleaning Shunt</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">HINGHAM,
Mass., Jan. 8, 2020 &ndash; Microbot Medical Inc. (Nasdaq: MBOT) has received an official communication from the European
Patent Office (EPO) regarding its intention to grant European Patent Application No. 11795301, covering the Company&rsquo;s
Self-Cleaning Shunt (SCS&trade;). Globally, the Company now has 36 patents issued/allowed and 16 patent applications pending
worldwide.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;We
have always maintained that a strong and growing intellectual property portfolio is one of our strongest assets and&nbsp;will
enable us to maintain a sustainable competitive advantage while establishing barriers of entry to future competitors&rdquo; said
Harel Gadot, Chief Executive Officer, President, and Chairman. &ldquo;We will continue to expand and seek protection for our unique
innovative platforms. This provides the foundation for the establishment of a multi-generation product portfolio, including our
latest introduction of the LIBERTY<SUP>TM</SUP> Robotic System, the world&rsquo;s first fully disposable robotic system for use
in neurovascular, cardiovascular and peripheral vascular procedures.&rdquo;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 40%; font: 10pt Times New Roman, Times, Serif; text-align: center; border: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><IMG SRC="ex99-1_001.jpg" ALT="" STYLE="height: 160; width: 186"></FONT></TD>
    <TD STYLE="width: 60%; font: 10pt Times New Roman, Times, Serif; border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0.1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
        have always maintained that a strong and growing intellectual property portfolio is one of our strongest assets and&nbsp;will
        enable us to maintain a sustainable competitive advantage while establishing barriers of entry to future competitors-Harel
        Gadot, CEO, President and Chairman of the Board, Microbot Medical.</FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0.1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Click
        to tweet link:</FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0.1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>https://ctt.ac/9DV2b</U></FONT></P></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
allowed patent application covers an inlet head for use on shunts, such as Ventriculoperitoneal (VP) Shunts which are implanted
in Hydrocephalus patients for draining excess cerebrospinal fluid (CSF). The inlet head includes a tube with openings disposed
in its wall, and a cleaning element comprising a central shaft with protruding bristles installed inside the tube, such that mutual
vibratory motion between the cleaning element and the tube causes the bristles to move within the openings. Such movement maintains
the openings clear and thereby prevents shunt occlusion.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>About
Microbot Medical</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Microbot
Medical Inc. (NASDAQ: MBOT) is a pre-clinical medical device company that specializes in transformational micro-robotic technologies,
focused primarily on both natural and artificial lumens within the human body. Microbot&rsquo;s current proprietary technological
platforms provide the foundation for the development of a Multi Generation Pipeline Portfolio (MGPP).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Microbot
Medical was founded in 2010 by Harel Gadot, Prof. Moshe Shoham, and Yossi Bornstein with the goals of improving clinical outcomes
for patients and increasing accessibility through the use of micro-robotic technologies. Further information about Microbot Medical
is available at http://www.microbotmedical.com.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Safe
Harbor</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Statements
pertaining to the future financial and/or operating results, future growth in research, technology, clinical development, and
potential opportunities for Microbot Medical Inc. and its subsidiaries, along with other statements about the future expectations,
beliefs, goals, plans, or prospects expressed by management, constitute forward-looking statements within the meaning of the Private
Securities Litigation Reform Act of 1995 and the Federal securities laws. Any statements that are not historical fact (including,
but not limited to statements that contain words such as &ldquo;will,&rdquo; &ldquo;believes,&rdquo; &ldquo;plans,&rdquo; &ldquo;anticipates,&rdquo;
&ldquo;expects&rdquo; and &ldquo;estimates&rdquo;) should also be considered to be forward-looking statements. Forward-looking
statements involve risks and uncertainties, including, without limitation, market conditions and the satisfaction of customary
closing conditions, risks inherent in the development and/or commercialization of potential products, including LIBERTY, the outcome
of its studies to evaluate the SCS and other existing and future technologies, uncertainty in the results of pre-clinical and
clinical trials or regulatory pathways and regulatory approvals, need and ability to obtain future capital, and maintenance of
intellectual property rights. Additional information on risks facing Microbot Medical can be found under the heading &ldquo;Risk
Factors&rdquo; in Microbot Medical&rsquo;s periodic reports filed with the Securities and Exchange Commission (SEC), which are
or will be available on the SEC&rsquo;s web site at www.sec.gov. Microbot Medical disclaims any intent or obligation to update
these forward-looking statements, except as required by law.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Investor
Contact: </B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Michael
Polyviou</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">EVC
Group</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">mpolyviou@evcgroup.com</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">732-933-2754</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>



<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>ex99-1_001.jpg
<TEXT>
begin 644 ex99-1_001.jpg
M_]C_X  02D9)1@ ! 0$ 9 !D  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" #& .8# 2(  A$! Q$!_\0
M'P   04! 0$! 0$           $" P0%!@<("0H+_\0 M1   @$# P($ P4%
M! 0   %] 0(#  01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T? D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$  P$! 0$!
M 0$! 0        $" P0%!@<("0H+_\0 M1$  @$"! 0#! <%! 0  0)W  $"
M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#^_BBBB@ H
MHHH **** "BBB@ HHHH ***JSOM9CNP(XP\F 6**2^UBH!9MQ1@ @8Y!R .:
M +)902"0"!N.>,#D9R>.Q[U@>(?$>B>&M(O=>U_6M-T#1--A-QJ6LZO?6&FZ
M5IT 8()K[4K^>WLK:-I7BA5I;A09)8QT8L.,^*'Q/\ _"#P9XB^(?Q1\4Z/X
M/\!^&=-34/$FO^(+ZWTK2=+M#*\5O+=W=U)#Y#75V\-I#&RB2>65%A5PDYA_
MSR_^"D/_  6A_: _;BU;XE>%?!&O:7X#_9V\%:S]FLOA7+:^'+Z/Q[X:T'Q_
M9Z$_B#QWH][%J:^--4FN;E;NP\!6-UKYTO2[/PWXLL[6P'B9KU^?$U72I.<7
M=Q7O6>S\[V_4Z<)AYXBJH<K]YVCI?F7DKZ^6Q_4G^T__ ,' G[&7P*\17/A'
MP!<Z[^T'K*Z/-OUSP";>S^']GXANKS2H] TG4?'%Q,CRVQM]1AU:\O= T[6;
M4:7JMHUM+=71NK6V_+B^_P"#G#XO:I8ZQ!X>^ 7POT;6+7P[-J4*ZIK_ (A\
M4:;;RR:"FHQ65OJ4%_X5M]7U;S;>Z+:1JD>EP1->Z09=9SJD=O;?RBWN@Z]X
MEN(=;M]7\'^)+'2=/GDN-$TBSO\ 1+?3[G3X;O3_  _X36RUBU\*77]I:=HO
M@_3+9;6:UUNWM;__ $1/$DMA##;Z=WOACX:MJTUQ?^)?#D4UQILD-KI,@O9+
M&UM!X?@U".YU.X.@W5Y&6M/M%WHYNIHA=3R7=C96ERUG)K%LWR=?/_9SGS5H
M12DUK+;;R9]CA.%JE3EE]7J/F2?PK_Y)+[C^D+_B),_;(,U\NE_"#X!:AI@O
M-#L1JI^'OQ,G;3KVY_M.PU>TOK#3?C%#HD^JZ<=(O-4N]&'BMKN#3K= +7^T
MI[/39_7O 7_!S-\0].UA+;XS_ +P2OA^WCT2]7Q)X=NO%W@:#5M-DM;J3438
MVVI2?$FQN-7U;[-_9OA70-,UG4'OM5\1>$)KF?3]'U*\UJP_G+T_P5K7BY]5
MTRSM]=FTZSM_%(T?3X-*T^#5-.@TU_"NL:R]Y<:/#;1S6$>J:9'<6TZZW<:=
M;6V@7EQ9Z*M[H-CIUCG?$?X-6OA^ZU;7XM$N=,O[+5;RR-]/I.AZ)/J^A:3J
M^GWFE>*/&6D>';C6KK2+L3W<EY?:1XKNQ=:+JNK:AH7B&\.N^$==-KDN*E%)
M1Y9I;235I>:ND_P6QZ;X-K6YOJ=5)ZI\D=MKK]Y^E^I_?G^RU_P6-_8B_:=7
MP[H^D_%S1OAUX\\265]J5O\ #[XGZIHN@>(+4VMS*D^G3W\&K:AH9U'=%=7E
MEI<U_8ZTVA0V^JW6C6=E/:S7/ZL6NH0WEO;7%LXFBNH!<0-$T<BR1!8]S*RL
M5RCRI&X9@5D)_@5G'^4G=^!-<T;P?H7D^''O-=TK3[#3=)M]1\5ZOH<6B:&H
MUEK>>_>]EL6TW6[&SU#2/"T'A[P[%>^(T-K;^+K33M6N-+3P_K7ZI_L,?\%P
M?VA?V0=2D^'/Q!L=<^-/PBUF;2]#TJT\9:OXBL8O"UM;:]K\4$OA#6]874+S
M0TU&QT[7FUS0?$-]'X9T#3K"..Q\6Z]X@B.FU[>6YS3QDHWJTU*2U@W=K5Z-
M6>NST[_?\QFW#.(POM:JA.$%)MW5E'2/9NUM]FM?N_T)H91-&)!G#8(R,':P
M#*2O5=RE7"L X5AN56R!+7F?PH^*7@;XO>!-"^(/P]\5^&_&GA;Q#;K=6NO^
M$];L/$.BM.8!+?VHU;3[JYM99K&[6>UFB67S+<K%&\2+M8^CQ3+,"0"K X9&
M:-F0X# -Y;R*"R,C@!C\CJ3C.*]]ZWDK.*ZK;;^NA\NFHV@Y)O9/7WM7KJOS
ML2T4@((R*6I332:=T]F5L%%%%, HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH *IW$C+(NU=Y4Q$894\M99&CFED+N RI"'E1%5C^YD+?PXN5YG\5/B!X7
M^&/@OQ3\0_&E]8:1X0\"^&-;\7>)M:U.6XAL=*TC1-.NKJ_NKMK6WNIC!%I*
M:K.?+AD(:#Y_+!62FDW>VMM_(3DDTF[-[+OZ'\0W_!S5^WIXO\8?$?3OV/OA
MUHVM6'AWX(^+E\2>/?$%A=7UVOC?Q1J7@.TN+6P#06EWI4EGX1T3Q%K::YHF
MN6LKRZMI\XT&VO)+"*YD_EZ\/Z%XU\5ZKHVJ$7-]JMKIWA)-+U_P[#%:ZMX;
MLQHMEX;TS3RGA".361I@LM)TR3Q5?V5UJOFZ[X?U^(W<EW9R64'T[^T1\;M0
M_:-_:6^+7Q;\1:K/J&J_%3QKXNU"73='\4^'?"FJC3/$EYJOBVS\*6NLZJ7O
MKB>+^R(;?7O#VA1W5W?^%/$4%OI^JZ9?R/!=?5O[.7P6MQ>3:KJ&E307+BYT
M*^34M,GEUB]G\+ZIJOA_P\A36]8U/3M&LYO"%S'J=Q;V6DP6@O[T7T5[J%Q?
M7M]7Q?$693PN'Q;@]$Y6L^T5_5S]"X1RI8[%82'(Y2?+>*2O?FEIJUT\^HW]
MGG]G+Q'KTUUX@O[9+R.>ZE$4%XT<4-@]S)-I]QJEA#=:5'J<M_?!+F_>WUR2
MXN4N=2N;AM3=9T@MOT1?X'6UEIYU>^\(6^DZ=:S^'=4A\J+2YET;5M-U^(Q7
M=B]W+;V]K9VT UC79[F^D\.WFOZUJ4&C6%YJ8L62R][^$/AS0-#,4%IID$UQ
M+?64]VLDLUQ!;);QPQO%:2/=7,+0;46119K:6?VE[@+;1N))9?TL\ ^&O"]\
M\.I3V5FUS"EY;6EZ]I')<Z=9ZA%&+Q=,4R!;:ZE7:ANXY(Y-N%<2HB)7X)5S
M?$XO%5E[=I.I*T;O3;3;\#^C:>0PPF'IKZK)RIPBIOECH[-N_O>:[GY#> ?@
M'<ZRVM:C<Z1+XG\"Z9XBO$MD\;^&=.L1>ZA-->>)KC4E\)^+;3^V9-7O;J?1
MVANO$RV\\&KZ_I=Y;G5?#^CV4&MW/BK\/]9\":9YOB?4PC7WBKQ=+$UK>:'X
M5TNWN/BGJWB>R\47.O6!U'3/!T.EW.N:IJ_B_7[)O$VL:AD:[<3:3I>A/>^)
MD_=KP_X!T;6E@LKJV:WM[5=/:TMUN([J&,6&HM<!'EDTZ$RBZB$,\\H@B/VJ
MWBB\MT4W+P^+/V)_@]XNMK&?5)/$*74!WM>:;K^H:7?2W4<MC)'>&ZL'@19)
M/L"R7-O-:74#F_U.UE-Q87MW;77H4<)C:\%.GB)--7=I/3?3==NAY&+Q>'HO
MV<H1BUHDUK^"?<_)O7_@ OBGP=>32:?!XDO+?4;JXT5_$MGX0\0OIMK?0KX<
MDT+Q0UZOB*WTOP/K3V.H:AX[\#+KL^NZSJ=QH<^HS:?'>/:Z1^0'[;/[(VD^
M!]0MIB^E:8=1UW1X]#GM=,2\2WLI+/0+2>?Q%I7@G4O$EOI7AOP_=>%OM.CR
M7JZC=V^H6D?A9=(/AP76N#^OC3O@;\,?":2)9Z4;N_&KVNJW6JWOV636=8N[
M..ZLQ?ZUJ\EK/J&J:A=V;:>UY<7$Q>:ZTRWDEDFF::YD\@^.WP$\(_%WPI?^
M&-1BU"ZMM5MY5N&GU.*>WDU>WL)--T_4[]6AM[^&"RL;[69?[.BU6+3)K[6I
MY]BS6WFS=F5XC'Y;BYU)5Y5(QG\/,W9)+S]3S\5@L+F&!JOV*DW%N5DM'9[W
MMTMW/PV_X-\/^"@%S\"?VE$_9)\9^)/"D?PU^,^L:2HO=7N;O2G\%_%*6PUC
M4] 3PYI$<"6^E#XI6C:)87=SK>E^'O#C:EY.FV&K7VJVNM6-A_?):7D<I;:7
MD!*%7&TKMDBBF&!LA=5_>90/&&:/9*#LD0#_ #"OC]\"-9_9T^+=AJOAV\L[
M'Q#\+OBI9?$+P=JEFVH3WN@:MJT<5M!XSOM%N/#EK'J.F7?B;PK9VGAS2D\2
M>+(1JVI:M9>&M!:\M[VZN?\ 2'_9K^-/A[]H?X)?#'XR>$[JUN=%\?\ A&QU
M[;:K=QPV&J%YK/Q#HA@OX8+^TNM \0VFJ:)?V-Y$DMC?Z?<VGS1PQFOW#AW-
M?[1PL93DG*<%)J[NG>2MM_=VOU/Y[XDRKZEBY3A2<:7M)<CLE'E5M59W_FZ+
MT/?EQ\V#D;C_ "''X4ZHXE55^7.&);GWP/4^GK4E?0Q5DEV_S?\ F?.O5_UV
M04444Q!1110 4444 %%%% !1110 4444 %%%% !112$X&: %K\V_^"M&M7/A
MS_@GY^TQ?VFIC2+B[\#:?HLUY-9I>V4VG>(O%&C>%]5TB[CG,=FL.N:3X@O]
M(EDNKB&-?MB-DA69/T>-Q&.I()61@,<D1A2_3(& PZD5^-?_  7@\3Z;H/\
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M;BXCW6PFA:)+DS1I);S312;3+"\D3I(WV)X\^)^D_#RQCOM=O#I\1V@-=1-
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M>8P(%;7[N2PLFC\^$;))/(O(843[5&A,6Z+G<P,D<BYE$;D@Y4*%+=52$JV
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M3XJTK1=!U[P+K/BO\W]-L+1/#45Q]ELWT[4(GBL[ (EC8QZ;(##"WFVL8NK
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M,[<*$/0'&.!U.Q;W.G012332I=$!5*V\4L1$V?E4I>1VC-&O!WA6')"DD%0
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MK^%[/Q# =+N/W-E;L;S1]3TZ1X[RUN(8+B[E6-_D7][J-TD\49E&39VY<)G
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M*?\ X*4?M3VEU':>39_%OQ!*?.2YBD,-YIVE&%B@EMU)#!PYVG!!"NX&U?\
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MF$%(7C23*R2-(6978A?*W1KF/.<9V_-NP#U/17ELZ3!)B$+0784MN"D_9'N
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%;W8'_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>ex99-1_002.jpg
<TEXT>
begin 644 ex99-1_002.jpg
M_]C_X  02D9)1@ ! 0$ 9 !D  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" !C /X# 2(  A$! Q$!_\0
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MV<XP<8Z9_I4U-90V,]OIW^H]J /@_P#X*&>$I_$W[,OC)].B;[3H$VG>) V
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M:O4<79II7K!YWMU-Q_K"6)Y!^7)"\CCH,_CS4TS[ IW*H^;)9@H 5=Q))(
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M_92Z'+&,G!249<K5T[.S5]T[)6_KS/VZ+@XV?,""=P!*\8_C'RCKT)R>W0U
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M3LLTN2" ,XE*GRP?[%?@]XGO_&7PO\">+]6$:ZEXF\+:-K-_L4JWVV[LHFN
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M3^'-(\6:_J/BBZ\/:<NKV%G<BWTZS2Y):)KN&40%S=2+A?+<&,,5.(Z^./\
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M3=Q:9;%Y 2B^4H9E+ '^B[PP5;PSH15AL73-)8-R,B.TM=V <'@J?KSC/?\
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M5#L*SVES$Z-'(A\[:()&8Y7(X!K^G%G@CF96DC#QJ6="REU7Y<'8#NRX;Y%
M)<Y"!B"!)O3S' 0-A-[GG=$HVGYQ@^4[!@5B?;(^T[%/EN5)SQ:C36#K?5W=
M^W:;C[:-]FUO[KY>W3=&4H>VE)25E32<&]%)VO[M[7U>WJ?R/:9_P2D_;?U7
M6/L6J6_@30K.*;[-%K-Q?:?JEWY*Y$=]'-_:<]RZ+R8XI8Q,F>4&X5^G/[+7
M_!)'PA\&+:?Q;X^\:ZCXH^,%WLFM?&5I*T'_  B[0O(!+HB.-J332W5NK-C
M%O'SR<?M(T@=BBMD%4<E]HV*^=@W' 5FVMF-R'P!D 'E)8K8+LE,(A 42-*Z
MH-V]#$,L5&'9<]?F*KC.*Y,=@\)B^;VCQ4&TKQI>T<+J*C*22BOBE>32ZMG7
MALPQV$C&6'I8=N=XR<U'VB2;BN;FB^B5KW]VW0^2M8\-7FM^$[WX5_M#^'M*
M\<>$]7C?1H]=>&.ZBU"T$<]M;7FJQ,9;JUULY!2]2!+9I4D<RX4D_CO\8?\
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63QRX_H*** +*@!8\=^3^8J>BB@#_V0$!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
